The patient experience of CHAPLE disease: results from interviews conducted as part of a clinical trial for an ultra-rare condition

Abstract Background CD55 deficiency with hyper-activation of complement, angiopathic thrombosis, and protein-losing enteropathy (CHAPLE) disease is a newly identified condition with an estimated worldwide prevalence of < 100 patients. Patient interviews can ensure that what is important to patients...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Leighann Litcher-Kelly, Ahmet Ozen, Sarah Ollis, Hagit Baris Feldman, Andrew Yaworsky, Paolo Medrano, Voranush Chongsrisawat, Lorah Perlee, Marisa Walker, Sharanya Pradeep, Diane M. Turner-Bowker, Alina Kurolap, Orly Eshach Adiv, Michael J. Lenardo, Olivier A. Harari, Jessica J. Jalbert
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-02-01
coleção:	Orphanet Journal of Rare Diseases
Assuntos:	CHAPLE Within-trial interviews Pozelimab HRQoL
Acesso em linha:	https://doi.org/10.1186/s13023-024-03436-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!